Introduction
Coronary heart disease (CHD) is the leading cause of mortality due to myocardial infarction and of morbidity due to heart failure. In the past decades, mitochondrial dysfunction have emerged in both conditions central effectors of the pathomechanisms underlying both acute and chronic cardiac diseases as well as potential therapeutic targets (Bulluck et al. 2016; Waczulikova et al. 2007 ). Diabetes mellitus (DM), acknowledged as the pandemy of our century, is responsible for the diabetic cardiomyopathy, defined as the association of left ventricular hypertrophy/remodeling with diastolic dysfunction that precedes the development of systolic dysfunction and may progress to heart failure (Duicu et al. 2015a ). Doenst et al. reported a reduced respiratory capacity of isolated mitochondria in association with hypertrophy and impaired ejection fraction at 20 weeks in the rat model of transverse aortic constriction (TAC) and chronic pressure overload (Doenst et al. 2010) . Interestingly, the occurrence of contractile dysfunction at 20 weeks was no longer related to the ROS production in this model; moreover, the maximal ROS production occurred at 6 weeks after TAC concomitant with the onset of diastolic dysfunction (Schwarzer et al. 2014) . Similarly, in the rabbit model of pressure-overload hypertrophy, mitochondrial complex I and II dysfunction occurred independent of an increase in the oxidative stress during the transition from compensated left ventricular hypertrophy to failure (Griffiths et al. 2010) . Conversely, in a rat model of right-ventricular failure induced by pulmonary arterial hypertension, an increase in complex II activity and related ROS production were reported in mitochondria isolated from the right (but not from the left) ventricle (Redout et al. 2007 ). Abnormal cardiac energy metabolism and mitochondrial dysfunction are key factors in diabetic cardiomyopathy (reviewed in Bugger and Abel 2010) ; specifically, mitochondrial electron transport chain (ETC) defects with secondary drop in ATP synthesis and increase in reactive oxygen species (ROS) generation (Bugger and Abel 2014) occur in both diabetic rodents D r a f t 4 (Vazquez et al. 2015) and humans (Anderson et al. 2009 ). Thus, protecting mitochondrial function in cardiac diseases and diabetes represents a research priority for the academic community worldwide (Murphy et al. 2016 ).
Methylthioninium chloride, also known as methylene blue (MB), has been systematically investigated for its beneficial effects mainly in the treatment of neurodegenerative disorders such as Alzheimer and Parkinson (Oz et al. 2009 ); collectively, MB is widely recognized as being neuroprotective both in chronic neurodegenerative diseases and acute brain injury (reviewed in Jiang and Duong 2016) . MB was also reported to attenuate ischemia/reperfusion (I/R) injury (Kelner et al. 1988 ) and increase the survival rate following experimental cardiac arrest in association with decreased oxidative myocardial damage (Miclescu et al. 2006 ).
Because mitochondrial function depends on redox components, drugs with redox activity have been increasingly used as mitochondrial modulators to enhance energy production and decrease oxidative stress (Atamna et al. 2012) . As a redox active agent, with a mild redox potential (10 mV), MB is enabled to readily cycle between its oxidized and reduced form -MBH 2 (Atamna et al. 2012) . It has been proposed that MB is reduced by NADH dehydrogenase of complex I and reoxidized at cytochrome c, thus acting as an alternative electron carrier between NADH and cytochrome c (Atamna et al. 2012) . This improves mitochondrial function and provides a mechanism to bypass complexes I and III, known to be the major sites for electron leakage and ROS production (Watts et al. 2013 ). Importantly, the protective effect of MB follows the pharmacological principle of hormesis, with an optimal effect only at low doses. In line with this principle, we have recently demonstrated that in vitro administration of MB (0.1 µM) increased both oxygen consumption rate (OCR) and extracellular acidification rate (ECAR), the two parameters of oxidative phosphorylation (OXPHOS) and glycolysis being assessed by the help of the extracellular flux analyzer Seahorse XF 24e (Duicu et al. 2015b) . Of note, all OCR-D r a f t 5 linked parameters and ECAR were decreased in a concentration-dependent manner when MB was administered in higher concentrations (1, 5, and 10 µM), and were not influenced by the lowest concentration tested (0.05 µM), respectively (Duicu et al. 2015b ).
Since impairment of respiration and increased ROS production are the major pathomechanisms underlying the progression of diabetic cardiomyopathy towards heart failure, we thought to investigate whether MB could improve mitochondrial respiration and alleviate oxidative stress in the presence of diabetes mellitus.
Materials and Methods
Animals had free access to water and fed on the normal laboratory rat chow throughout the experiment period of 8 weeks. Rats were housed under standard conditions (fully ventilated cages, in a temperature-controlled environment of 22 ± 2° C with a 12/12 hour light/dark cycle).
Experiments were conducted in accordance with all guidelines for animal ethics and followed the Canadian Council on Animal Care (CCAC) guidelines. The experimental protocol was reviewed and approved by the Ethics Committee of the University for Medicine and Pharmacy of Timisoara.
Experiments were performed in adult Sprague Dawley (SD) male rats with (n=8) and without (n=6) diabetes mellitus (DM). Diabetes was induced by a single injection of streptozotocin (50 mg/kg STZ, IP). Age-matched control rats received an equal volume of vehicle (0.01 M citrate buffer, pH 4.5). Rats with non-fasting blood glucose (NFBG) over 200 mg/dl were considered diabetic. Animals were sacrificed after 2 months, while NFBG and body weight were regularly monitored.
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Isolation of Cardiac Mitochondria
Rat heart mitochondria (RHM) were isolated by differential centrifugations at 4°C, according to a previously described method (Duicu et al. 2013) . Briefly, ventricles were treated with subtilizin (5 mg/g of wet cardiac tissue) and homogenized with a tissue homogenizer (Glas-Col 099C K5424 CE). Tissue homogenate was further centrifuged (Rotina centrifuge 38R) for 10 minutes at 8500 g; the pellet was resuspended and centrifuged for 10 minutes at 800 g. Lastly, the supernatant was centrifuged at 8500 g for 10 minutes. The final pellet of mitochondria was resuspended in a glass homogenizer, kept on ice, and used within four hours in respiratory rates measurements. The mitochondrial protein concentration was further evaluated, according to the Biuret method (Gornall et al. 1949 ).
High-Resolution Respirometry Studies
The oxygen consumption was measured at 37ºC with the Oxygraph-2k (Oroboros Instruments, Austria). The mitochondria (0.1 mg protein/ml) were incubated in 2 ml of incubation medium containing 0.5 mM EGTA, 3 mM MgCl 2 .6H 2 O, 60 mM K-lactobionate, 20 mM taurine, 10 mM KH 2 P0 4 , 20 mM HEPES, 110 mM sucrose, 1 g/l BSA, essentially fatty acid free + 280 U/ml catalase lyophilized powder, 2,000-5,000 units/mg protein (pH 7.1, 37°C). The SubstrateUncoupler-Inhibitor Titration (SUIT) protocol adapted from Duicu et. al (Duicu et al. 2013 
Mitochondrial H 2 O 2 Production Assessment
Mitochondrial H 2 O 2 production was measured using the Amplex Red (10 µM) fluorescent marker, as previously described (Duicu et al. 2013 ). The excitation wavelength was set to 530 nm and the emission wavelength to 590 nm. Mitochondria (0.25 mg protein/ml) were incubated in 2 ml incubation buffer (250 ml sucrose, 1 mM EGTA, 1 mM EDTA, 20 mM Tris/HCl and 1.5 mg/ml defatted BSA, pH 7.4) at 37ºC, supplemented with glutamate + malate ( 
Calcium Retention Capacity Measurement
To assess the in vitro sensitivity to Ca 2+ -induced mPTP (mitochondrial permeability transition pore) opening, the calcium retention capacity (CRC) was measured according to a technique D r a f t 8 previously described (Duicu et al. 2013) . Measurement of calcium uptake by fresh RHM (0.25 mg protein/ml) was performed at 37°C in 2 ml incubation buffer (150 mM sucrose, 50 mM KCl, 2 mM KH 2 PO 4 , 5 mM succinic acid in 20 mM Tris/HCl, pH 7.4, at 37°C) using a Hitachi F-7000
spectrofluorometer. The change in extramitochondrial Ca 2+ concentration was monitored using the fluorescent probe Ca-green-5N (1 µM; excitation-emission, 500-530 nm). CaCl 2 pulses (20 nmol/pulse) were added every minute until a rapid increase of fluorescence occurred, signaling the opening of the mPTP. CRC was calculated as the cumulative amount of Ca 2+ taken by mitochondria before Ca 2+ release.
Chemicals
Calcium green-5N and Amplex Red were purchased from Invitrogen and cyclosporine A from Novartis, respectively. All the other chemicals were from Sigma-Aldrich.
Statistical Analysis
Data were expressed as means ± SEM. Data analysis used one-way ANOVA followed by a posthoc Tukey test (GraphPad Prism v. 5.0 Software, SUA). Differences were considered statistically significant at p < 0.05.
Results and Discussions
In diabetic animals, as expected, a reduced body weight and an elevated plasma glucose concentrations were measured (Table 1) .
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High-Resolution Respirometry Studies
MB elicited a substrate-independent improvement in respiratory function as demonstrated by the increase in all respiratory parameters (i.e., State 2, OXPHOS, State 4, and ETS) in both non-diabetic ( Fig. 1 A, B) and diabetic ( Fig. 2 A, B (Tretter et al. 2014 ).
In our hands, MB improved both basal and ADP-stimulated respiration, as shown by an increase in OXPHOS for both substrates, most probably by serving as an additional source of electrons for the ETS (Gonzalez-Lima and Auchter 2015): in non-diabetic group, MB increased OXPHOS by 29.8% in mitochondria energized with glutamate+malate and by 27.7% in mitochondria energized with succinate(+rotenone), while in diabetic group, MB increased OXPHOS by 24.4% in mitochondria energized with glutamate+malate and by 16% in mitochondria energized with succinate(+rotenone). The mild redox potential enables MB to cycle between its oxidized and reduced forms, providing a mechanism to shuttle electrons among 2 redox centers (i.e., oxidizing NADH via complex I and reducing cytochrome c) (Atamna et al. 2012 ). It has been hypothesized that, in the presence of MBH 2 (with NADH as the major electron D r a f t donor), cytochrome c is reduced above the normal enzymatic reduction by complex III leading to increased cytochrome oxidase (complex IV) activity and subsequent oxygen consumption (Atamna et al. 2012 ).
In line with the previously mentioned hormetic behavior, it is important to emphasize that the beneficial effects of MB were observed at very low doses (i.e., 0.1 µM). In high concentrations, it has been speculated that MB could "steal" electrons from the ETC complexes resulting in a disrupted redox balance (Rojas et al. 2012) . Accordingly, Tretter and colleagues also remarked that MB partially restored respiration if electron flux was inhibited at either complex I or III (Tretter et al. 2014 ). This might be of particular importance in I/R injury where a massive release of ROS damages various cellular structures, including mitochondrial respiratory complexes, contributing thus to diminished metabolic activity and increased ROS production.
Our data also demonstrated that experimental diabetes was associated with mitochondrial respiratory dysfunction, as previously reported in chronic (Bugger and Abel 2010; Bugger and Abel 2014) , as well as in acute diabetic heart (Ferko et al. 2006 
Mitochondrial H 2 O 2 Production Assessment
The effects of MB (0.1 µM) on ROS production were further assessed in RHM respiring either on complex I or complex II substrates, using the Amplex Red technique. Rotenone (complex I inhibitor) was used in combination with succinate to prevent oxaloacetate accumulation, which is a strong competitive inhibitor of succinate dehydrogenase; additionally it prevents the reverse electron transport (RET) from complex II to I, known as a major ROS producing-process during succinate oxidation.
As expected ( Interestingly, the addition of MB (0.1 µM) significantly increased H 2 O 2 production in both groups (with/without diabetes) when mitochondria were energized with glutamate+malate (in diabetic group by 210%, and in non-diabetic group by 78%), whereas a significant decrease was observed when succinate (+rotenone) was used as substrate (in diabetic group by 49%, and in non-diabetic group by 53.8%) (Fig. 3 A, B) .
The former result regarding mitochondrial H 2 O 2 production was rather surprising view the antioxidant effect of MB described in the literature (Ryou et al. 2015; Poteet et al. 2012) . There is only one study in the literature (by Tretter et al.) that reported an enhanced H 2 O 2 production with MB in isolated guinea pig brain mitochondria respiring on both glutamate+malate and succinate+rotenone (Tretter et al. 2014 (Atamna et al. 2008) . In this view, they suggested that a high ratio between cytochrome c and MB is fundamental in order to prevent autooxidation of MBH 2 , since an excessive cytochrome c addition to the mitochondrial lysate, NADH, rotenone, and MB significantly eliminated the production of oxidants. (Atamna et al. 2008) According to Gnaiger, in rat heart mitochondria, the oxidation of succinate (+rotenone) is marginally higher compared to glutamate+malate (Gnaiger 2014) . As a consequence, a saturation of cytochrome c and the subsequent enhance in H 2 O 2 production should have more likely occurred with the complex II substrate (and not with complex I substrates), indicating that direct reduction of O 2 by MBH 2 to form ROS cannot explain our observations. As MB accelerates the oxidation of NADH by serving as an additional electron acceptor, a smaller NADH/NAD + ratio is expected, therefore excluding this site as a cause for enhanced ROS production with glutamate+malate as substrate (Rojas et al. 2012) . In addition to the commonly accepted concept that MB donates its electrons to cytochrome c and downstream, Rojas and colleagues also consider coenzyme Q as a putative MB target (Rojas et al. 2012) . In this respect, as MB independently supplies electrons to the coenzyme Q pool, this could allow the occurrence of RET in mitochondria respiring on glutamate+malate. The second site at complex I, the CoQ-binding domain 1Q, is of particular D r a f t 13 importance during succinate-supported respiration, as it constitutes the major locus for ROS generation during RET. While 1Q is negligible during regular forward electron transport with glutamate+malate, it could constitute a major ROS-generating site in the presence of MB. This hypothesis is supported by the work of Muller et al. who reported high superoxide production in mitochondria respiring on glutamate+succinate, that was decreased by rotenone and completely abolished by the uncoupler FCCP, indicating RET as a cause (Muller et al. 2007 ). It was concluded that RET mediated superoxide production can occur under physiological realistic substrate conditions, but oxaloacetate inhibition of complex II is meant to minimize that (Muller et al. 2007 ). We cannot exclude the fact that RET might occur during physiological, complex Isupported respiration and that MB, independently of oxaloacetate inhibition, could deliver electrons to the coenzyme Q pool; in these conditions 1Q site might become the potential candidate able to explain the increased ROS production that we observed with glutamate+malate.
Nevertheless, we admit as important limitation of our study the fact that we did not measure the mitochondrial membrane potential, especially since Waczulikova et al. demonstrated a slight decline of the membrane potential concomitant with an increased membrane fluidity in acute (i.e., 8 days) streptozotocin-induced diabetic rat hearts (Waczulikova et al. 2007 ).
Membrane potential is thought to slow down electron transfer between heme b L and heme b H thus supporting a more reduced heme b L which then increases ROS production (Bleier and Drose 2013 ). If we apply this model on MB and hypothesize that, despite some uncoupling action, membrane potential was increased with both substrates, leading to a more reduced heme b L , the main determinant of ROS production would be the redox state of coenzyme Q pool. Dröse and Bandt showed in submitochondrial particles fueled with succinate that an increased ROS production from complex III occurred with the inhibition of succinate dehydrogenase (SDH) to a certain threshold (Drose and Brandt 2008 mechanism could still provide a reasonable good explanation for our observations. A study by
Quinlan and colleagues conducted on mitochondria isolated from rat hind limb skeletal muscles
showed that in the absence of antimycin A (CIII inhibitor), succinate+rotenone produced approximately twice the amount of ROS at Qo as compared to glutamate+malate (Quinlan et al. 2013 ); these results suggest that an over reduction of coenzyme Q pool might indeed have led to changes observed in our experiments.
Calcium Retention Capacity (CRC) Measurement
The in vitro capability of mitochondria to uptake calcium prior the opening of the mitochondrial permeability pore (mPTP) or the calcium retention capacity (CRC) was assessed in isolated RHM in the presence vs. the absence of the classical pore desensitizer, cyclosporine A (CsA). As expected, with CsA we observed a decreased sensitivity to Ca 2+ -induced mPTP opening vs. untreated controls (Fig. 4) However, the addition of MB in either group (diabetic and non-diabetic) of mitochondria did not interfere with the capability of mitochondria to buffer calcium (Fig. 5) . The rationale behind this assay was to estimate whether the bioenergetic changes induced by MB could desensitize mPTP for calcium overload, since there are numerous factors able to modulate the phenomenon of permeability transition by changing the sensitivity of mPTP to calcium ions (Halestrap and Richardson 2015) .
Even though MB did not change sensitivity to Ca 2+ -induced mPTP opening in respiring mitochondria, whether this will be the case in mitochondria isolated at the postischemic reperfusion remains to be determined.
Conclusions
In conclusion, acute in vitro administration of methylene blue, in very low doses, improved mitochondrial respiration and elicited a dichotomic, substrate-dependent effect on ROS production in diabetes that clearly warrants further investigation in line with the highly-favored concept of drug repurposing.
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